C→U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme

被引:51
作者
Mukhopadhyay, D
Anant, S
Lee, RM
Kennedy, S
Viskochil, D
Davidson, NO
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pharmacol & Mol Biol, St Louis, MO 63110 USA
[3] Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Med Genet, Salt Lake City, UT USA
关键词
D O I
10.1086/337952
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termination of the edited mRNA. Previous studies demonstrated varying degrees of C-->U RNA editing in peripheral nerve-sheath tumor samples (PNSTs) from patients with NF1, but the basis for this heterogeneity was unexplained. In addition, the role, if any, of apobec-1, the catalytic deaminase that mediates C-->U editing of mammalian apolipoprotein B (apoB) RNA, was unresolved. We have examined these questions in PNSTs from patients with NF1 and demonstrate that a subset (8/34) manifest C-->U editing of RNA. Two distinguishing characteristics were found in the PNSTs that demonstrated editing of NF1 RNA. First, these tumors express apobec-1 mRNA, the first demonstration, in humans, of its expression beyond the luminal gastrointestinal tract. Second, PNSTs with C-->U editing of RNA manifest increased proportions of an alternatively spliced exon, 23A, downstream of the edited base. C-->U editing of RNA in these PNSTs was observed preferentially in transcripts containing exon 23A. These findings were complemented by in vitro studies using synthetic RNA templates incubated in the presence of recombinant apobec-1, which again confirmed preferential editing of transcripts containing exon 23A. Finally, adenovirus-mediated transfection of HepG2 cells revealed induction of editing of apoB RNA, along with preferential editing of NF1 transcripts containing exon 23A. Taken together, the data support the hypothesis that C-->U RNA editing of the NF1 transcript occurs both in a subset of PNSTs and in an alternatively spliced form containing a downstream exon, presumably an optimal configuration for enzymatic deamination by apobec-1.
引用
收藏
页码:38 / 50
页数:13
相关论文
共 55 条
[1]   APOBEC-1, THE CATALYTIC SUBUNIT OF THE MAMMALIAN APOLIPOPROTEIN-B MESSENGER-RNA EDITING ENZYME, IS A NOVEL RNA-BINDING PROTEIN [J].
ANANT, S ;
MACGINNITIE, AJ ;
DAVIDSON, NO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14762-14767
[2]   An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1:: Binding of Apobec-1 to this motif in the 3′ untranslated region of c-myc increases mRNA stability [J].
Anant, S ;
Davidson, NO .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (06) :1982-1992
[3]   Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: Structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase [J].
Anant, S ;
Yu, HR ;
Davidson, NO .
BIOLOGICAL CHEMISTRY, 1998, 379 (8-9) :1075-1081
[4]  
Anderson J.C., 1992, J BUS-BUS MARK, V1, P3, DOI DOI 10.1300/J033V01N01_02
[5]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[6]   Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 [J].
Ars, E ;
Serra, E ;
García, J ;
Kruyer, H ;
Gaona, A ;
Lázaro, C ;
Estivill, X .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :237-247
[7]  
Ashkenas J, 1997, AM J HUM GENET, V60, P278
[8]   3 DISTINCT RNA SEQUENCE ELEMENTS ARE REQUIRED FOR EFFICIENT APOLIPOPROTEIN-B (APO-B) RNA EDITING INVITRO [J].
BACKUS, JW ;
SMITH, HC .
NUCLEIC ACIDS RESEARCH, 1992, 20 (22) :6007-6014
[9]   ONLY CYTIDINES 5' OF THE APOLIPOPROTEIN-B MESSENGER-RNA MOORING SEQUENCE ARE EDITED [J].
BACKUS, JW ;
SCHOCK, D ;
SMITH, HC .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01) :1-14
[10]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715